C O V E R S T O R Y
Bio-based wound care solutions
Axio Biosolutions
Innovating novel biomaterials for advanced wound management
Ahmedabad based Axio Biosolutions is developing active medical products using novel biomaterials for advanced surgical and wound care . The company uses innovative medical technology to create breakthrough products for management of trauma , surgical and chronic wounds , and to save people ' s lives . Its flagship patented product , Axiostat , is India ' s first USFDA cleared wound care product that controls moderate to severe bleeding within minutes .
By innovating to create an affordable range of advanced wound care and hemostatic products , Axio is helping advance the use of newer technologies in these healthcare segments in India and other emerging markets . Its products are providing patients –
Company : Axio Biosolutions Location : Ahmedabad Year of Inception : 2008
Founder & CEO : Leo Mavely
Investors : Accel , University of California - Ratan Tata ( UC-RNT ) Fund , Omidyar Network India , and Chiratae Ventures
Latest Funding : US $ 6 million Series B2 equity raise led by TrueScale Capital , with participation from existing investors
including those from India ’ s Next Half Billion – with a high-quality affordable alternative to both traditional , less efficient products ( e . g . gauze , plasters , wadding ) and more advanced , expensive products ( e . g . foam dressings , hydrogels , sealants ).
Axio ’ s flagship product Axiostat that stops bleeding instantly is regularly used by many armed forces globally including Indian armed forces , BSF , NSG , and other para-military forces , as part of their trauma kits . Axio ’ s products are sold in over 40 countries
30
BioVoiceNews | November / December 2023